Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Neogenomics Inc

NASDAQ: NEO · Industrial Applications and Services · 3 alerts · CIK 1077183

Share price
$15.41Close, Nov 16
Market cap
$1.99B
Shares outstanding
129.39MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Testing LaboratoriesSIC 8734

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Neogenomics Inc filings on SEC EDGAR ↗

4:11 PM ET 10-Q
Financial Results

Neogenomics Q3 2026 Results: Net Loss of $7.55M, Loss Narrows

NeoGenomics reported a net revenue increase to $209.3 million for the third quarter of 2026, up from $187.8 million in the prior year. The company significantly reduced its quarterly net loss to $7.5 million compared to $27.1 million in 2025, driven by improved gross margins and lower general and administrative expenses.

Key figure
Net loss $7.55M
4:07 PM ET 8-K
Financial Results

Neogenomics Financial Results

NeoGenomics reported third-quarter 2026 revenue of $209 million, an 11% year-over-year increase driven by 29% growth in Next-Generation Sequencing (NGS) revenue. The company significantly improved its bottom line, reducing its GAAP net loss to $8 million from $27 million in the prior year, and raised its full-year 2026 revenue and adjusted EBITDA guidance.

“Our third-quarter results reinforce that we have the right strategy in place and the right team to execute against it. Clinical revenue growth of 13% continues to showcase the strength of our broad-based testing solutions portfolio, with NGS revenue growing a strong 29% and NGS test volume growing 17%.”

Tony Zook, Chief Executive Officer of NeoGenomics

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.